Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3epsilon chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers[1].
Molecular Weight:
(146.01 kDa)
Purity:
99.98
CAS Number:
[3037124-22-1]
Target:
CD3,PD-1/PD-L1
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted